Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

Professor Alan Soo, Consultant Cardiothoracic Surgeon at University Hospital Galway, with patient Sean Rankin from Newcastle in Galway City. Sean was the first patient to undergo the convergent ...

Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke ...

There is decreased risk for MACE, stroke, and mortality in patients with newly diagnosed atrial fibrillation who regularly use statins.

Cognitive performance may be improved and inflammatory markers may be reduced in older patients with atrial fibrillation who regularly consume coffee.

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

At McLeod Regional Medical Center, McLeod Electrophysiologists Dr. Prabal Guha and Dr. Cyrus Kocherla are performing safe and successful ablations in patients using the new FDA-approved pulsed field ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

A new study highlights that the experimental blood-thinner abelacimab significantly reduces bleeding risks in atrial fibrillation patients compared to standard treatments like rivaroxaban. In trial ...

Use of smokeless tobacco, cigars, and pipes increased the risk for coronary heart disease and heart attacks, according to a ...